Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pethidine vs Ketorolac vs Xylocaine Gel in Shockwave Lithotripsy
NCT03032458Phase 4Completed
- Sponsor
- Mansoura University
- Start
- Jan 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in procedural pain comparing Pethidine, Ketorolac and Xylocaine Gel (3 arms). Primary endpoint: Pain control assessed by NIPC scales at 10 months. Started Jan 2017; status: completed.
02
Drugs
pethidineketorolacLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT03032458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03032458.